Unlike in the rest of the country, where intestinal ultrasound rarely is used in the clinic, in New York City, gastroenterologists at Mount Sinai Hospital have made IUS findings the “the fifth vital sign” for inflammatory bowel disease patient care, particularly to monitor disease. Now, new research from the institution and other centers is showing that the tool can identify patients with endoscopic recurrence and possibly predict disease outcomes and treatment response.
Trending
- How Guardant aims to expand cancer screening with a blood test (Medtech Dive)
- Endoscope manufacturer faces $1M lawsuit after demo explosion (Becker’s GI & Endoscopy)
- AI-Based Red Density Score Predicts Clinical Outcomes in Ulcerative Colitis (GI & Endoscopy News)
- Machine Learning Improves Accuracy of Inflammatory Bowel Disease Identification Beyond ICD-10 Codes (Houston Methodist)
- No Surprises Act payment dispute process booms to $22.4 billion cost in 4 years: study (Medical Economics)
- PENTAX Medical and MAGENTIQ EYE Expand Global Partnership to Advance AI-Assisted Colonoscopy Worldwide (PR Newswire)
- Following Their Own Advice? Medscape Gastroenterologist Mental Health & Well-Being Report 2026 (Medscape)
- In-person therapist-delivered hypnotherapy versus smartphone-based self-guided hypnotherapy in IBS: a multicentre three-armed randomised controlled trial (GUT)
